By no means an expert, however, the anticipated delay till the results of the hotly awaited trial may see prices stay low (or go lower).
As stated, not an expert and I am aware that other forces will be at play, if the results of the study(s) (suggested to be completed in 2025 in another post) remain unknown, prices may languish for a little while yet.
But I agree, it represents an opportunity to buy in relatively cheaply (dumped half my modest holding in may for $20.05 each - waiting for the buy back in sign.....sellers to buyers 5:1 at the moment, so it may be a while yet).
The completion of the studies will hopefully provide the pre commercialization derisking that investors are waiting for.....
not advice. just saturday afternoon thoughts.
By no means an expert, however, the anticipated delay till the...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
-0.060(0.38%) |
Mkt cap ! $300.8M | |||
| Open | High | Low | Value | Volume |
| $15.72 | $15.85 | $15.51 | $1.660M | 117.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 312 | $15.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 626 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |